Zerion Pharma ApS

About Zerion Pharma ApS

Zerion Pharma ApS is a pharmaceutical development company improving the formulation of poorly soluble drugs (oral solid dosage forms) that are currently not reaching their therapeutic potential. Through the use of our proprietary formulation platform, Dispersome®️, we aim to develop new treatment options for patients across all therapeutic areas.

  • DK
  • 2021
    On CPhI since
  • 1 - 24
    Employees
Academic/Research
Contact info

Products from Zerion Pharma ApS

  • Dispersome® Technology

    Product Dispersome® Technology

    Dispersome®️ – A green technology for drugs

    The Dispersome® technology uses high quality whey protein, an environmentally friendly by-product from cheese production, to improve the solubility and bioavailability of poorly soluble drugs.

Zerion Pharma ApS Resources

  • Brochure Whey protein Dispersomes® show bioequivalence in rats

    Whey protein Dispersomes® show bioequivalence in rats
  • Brochure Dispersome® Technology

    Our proprietary Dispersome® platform is based around a class of novel excipients to formulate poorly soluble small molecule drugs into stable drug delivery systems
  • Brochure Advantages of Dispersomes®

    Up to 90 % of all new drug molecules are poorly soluble, which can be a problem as the drug must dissolve in order to be absorbed and reach its pharmacological target.

  • Video Dispersome® – an amorphous mixture

    Technology that is changing the future

    DISPERSOME®️ PLATFORM
    Our Dispersome®️ platform is based around a class of novel excipients to formulate poorly soluble small molecule drugs into stable amorphous formulations with a high drug load.

    IMPROVING OUTCOMESBy increasing solubility and dissolution rate the Dispersome®️  platform aims at improving bioavailability, therapeutic outcomes and convenience for patients.

    COMPATIBLE TECHNOLOGY
    Dispersome®️ formulations are compatible with standard solid oral dosage form manufacturing processes and facilities.